Ginkgo Bioworks Holdings, Inc. (DNA) stock
DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/301% below fair value
$9.61−0.62 (-6.06%)
Close on Nov 13, 2026Market cap $647.14MP/E –Yield –
Ginkgo Bioworks profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ginkgo Bioworks's profit margin for the twelve months ending Sep 30, 2026 was -192.0%. For fiscal 2025 it was -183.8%, against -240.9% the year before. The highest annual figure on record is -165.2% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -183.8% | +57.1 |
| FY2024 | Dec 31, 2024 | -240.9% | +114.1 |
| FY2023 | Dec 31, 2023 | -355.1% | +85.6 |
| FY2022 | Dec 31, 2022 | -440.6% | +142.5 |
| FY2021 | Dec 31, 2021 | -583.1% | −418.0 |
| FY2020 | Dec 31, 2020 | -165.2% | +55.1 |
| FY2019 | Dec 31, 2019 | -220.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -147.9% | +127.0 |
| Q2 FY2026 | Jun 30, 2026 | -231.7% | −77.7 |
| Q1 FY2026 | Mar 31, 2026 | -424.1% | −186.2 |
| Q4 FY2025 | Dec 31, 2025 | -127.3% | +117.9 |
| Q3 FY2025 | Sep 30, 2025 | -274.9% | −211.5 |
| Q2 FY2025 | Jun 30, 2025 | -154.1% | +232.3 |
| Q1 FY2025 | Mar 31, 2025 | -237.9% | +371.2 |
| Q4 FY2024 | Dec 31, 2024 | -245.2% | +301.2 |
| Q3 FY2024 | Sep 30, 2024 | -63.3% | +151.8 |
| Q2 FY2024 | Jun 30, 2024 | -386.4% | −132.4 |
| Q4 FY2023 | Dec 31, 2023 | -609.1% | −430.6 |
| Q3 FY2023 | Sep 30, 2023 | -546.4% | +462.8 |
| Q2 FY2023 | Jun 30, 2023 | -215.1% | +247.4 |
| Q1 FY2023 | Mar 31, 2023 | -254.0% | +96.7 |
| Q4 FY2022 | Dec 31, 2022 | -178.5% | +899.4 |
| Q3 FY2022 | Sep 30, 2022 | -1009.3% | −878.0 |
| Q2 FY2022 | Jun 30, 2022 | -462.5% | −338.9 |
| Q1 FY2022 | Mar 31, 2022 | -350.6% | −183.8 |
| Q4 FY2021 | Dec 31, 2021 | -1077.9% | −931.6 |
| Q3 FY2021 | Sep 30, 2021 | -131.3% | +64.6 |
| Q2 FY2021 | Jun 30, 2021 | -123.6% | – |
| Q1 FY2021 | Mar 31, 2021 | -166.8% | – |
| Q4 FY2020 | Dec 31, 2020 | -146.4% | – |
| Q3 FY2020 | Sep 30, 2020 | -195.9% | – |
See a number that looks wrong?